Reuters logo
MonoSol Rx sets IPO at 4 mln shares, $16-$18 each
August 29, 2007 / 8:46 PM / 10 years ago

MonoSol Rx sets IPO at 4 mln shares, $16-$18 each

WASHINGTON, Aug 29 (Reuters) - MonoSol Rx Inc. on Wednesday set its planned initial public offering at 4 million shares for an estimated price of $16 to $18 each.

The drug delivery company said in an amended filing with the U.S. Securities and Exchange Commission that Cowen and Co., CIBC World Markets, and Susquehanna Financial Group are underwriting the IPO.

MonoSol has applied to list its stock on the Nasdaq under the symbol “MSRX” MSRX.O.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below